Literature DB >> 25348303

Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.

Andrew W Woodham1, Adam B Raff, Diane M Da Silva, W Martin Kast.   

Abstract

Langerhans cells (LC) are the resident antigen-presenting cells in human epithelium, and are therefore responsible for initiating immune responses against human papillomaviruses (HPV) entering the epithelial and mucosal layers in vivo. Upon proper pathogenic stimulation, LC become activated causing an internal signaling cascade that results in the up-regulation of co-stimulatory molecules and the release of inflammatory cytokines. Activated LC then migrate to lymph nodes where they interact with antigen-specific T cells and initiate an adaptive T-cell response. However, HPV manipulates LC in a suppressive manner that alters these normal maturation responses. Here, in vitro LC activation assays for the detection of phosphorylated signaling intermediates, the up-regulation of activation-associated surface markers, and the release of inflammatory cytokines in response to HPV particles are described.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25348303      PMCID: PMC4955848          DOI: 10.1007/978-1-4939-2013-6_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response.

Authors:  Claudia N Renn; David Jesse Sanchez; Maria Teresa Ochoa; Annaliza J Legaspi; Chang-Keun Oh; Philip T Liu; Stephan R Krutzik; Peter A Sieling; Genhong Cheng; Robert L Modlin
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation.

Authors:  Steven C Fausch; Laura M Fahey; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

4.  Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.

Authors:  Steven C Fausch; Diane M Da Silva; W Martin Kast
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

5.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 6.  HPV: from infection to cancer.

Authors:  M A Stanley; M R Pett; N Coleman
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

7.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

Review 8.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.

Authors:  Miriam Merad; Florent Ginhoux; Matthew Collin
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

9.  Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity.

Authors:  Matthias Peiser; Juliana Koeck; Carsten J Kirschning; Burghardt Wittig; Reinhard Wanner
Journal:  J Leukoc Biol       Date:  2008-02-05       Impact factor: 4.962

Review 10.  Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation.

Authors:  Sarah A Cumming; Thanaporn Cheun-Im; Stephen G Milligan; Sheila V Graham
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

View more
  4 in total

1.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

2.  Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Laurie K Rijkee; Joseph G Skeate; Julia R Taylor; Maaike E Koopman; Heike E Brand; Michael K Wong; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Papillomavirus Res       Date:  2015-12-01

3.  Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.

Authors:  Diane M Da Silva; Andrew W Woodham; Paul H Naylor; James E Egan; Neil L Berinstein; W Martin Kast
Journal:  J Interferon Cytokine Res       Date:  2015-12-10       Impact factor: 2.607

4.  T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.

Authors:  Andrew W Woodham; Lisa Yan; Joseph G Skeate; Daniel van der Veen; Heike H Brand; Michael K Wong; Diane M Da Silva; W Martin Kast
Journal:  Papillomavirus Res       Date:  2016-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.